Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The large intestine mucosa is the innermost tissue layer of the colon and rectum, playing a vital role in the final stages of digestion and waste elimination. It is composed of a simple columnar epithelium, a supporting lamina propria containing immune cells, and a thin layer of smooth muscle known as the muscularis mucosae (StatPearls, 2023). Its primary biological functions include the absorption of water and electrolytes, the secretion of mucus to facilitate fecal passage, and acting as a robust immunological barrier against luminal pathogens and microbiota (NIH, 2024). In the context of pharmacology, the mucosa is the primary site of pathology for conditions such as ulcerative colitis, Crohn's disease, and colorectal cancer (PubMed, 2021). While many therapeutic agents are delivered to or act within this tissue, the mucosa itself is an anatomical structure rather than a specific molecular target. Drugs targeting this region typically interact with specific receptors, enzymes, or cytokines, such as tumor necrosis factor (TNF) or alpha-4 beta-7 integrin, located within the mucosal environment (PubChem, 2024). Consequently, Large intestine mucosa is considered a site of action or a tissue-level target rather than a discrete molecular entity.
Not applicable as this is an anatomical tissue layer rather than a specific molecular target. Therapeutic agents acting within this tissue target specific proteins such as cytokines, integrins, or enzymes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large intestine mucosa.